诱导液中的IL-25表达可能在患有支气管喘的儿童中作为可靠的生物标志物

相关实验视频

Updated: May 3, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

10.2K

Yun Zhang1, Yuna Chang1, Lu Cheng1

  • 1Department of Pediatrics, Jinan Children's Hospital, Shandong University, Jinan 250022 Shandong Province, People's Republic of China.

Clinica chimica acta; international journal of clinical chemistry
|May 21, 2025
PubMed
概括

对于患有喘的儿童来说,干白素-25 (IL-25) 的含量升高. 液中的IL-25水平随着治疗而降低,这表明它作为控制喘和治疗疗效的生物标志物的潜力.

关键词:
呼吸道的炎症 呼吸道的炎症抗喘治疗 抗喘治疗喘 喘 是一种童年 童年 童年 童年临床特征 临床特征诱导的吐引起的吐.介质素-25 介质素-25 介质素-25

更多相关视频

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples11:54

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples

Published on: January 21, 2018

29.9K
Isolation and Quantitative Evaluation of Brush Cells from Mouse Tracheas10:25

Isolation and Quantitative Evaluation of Brush Cells from Mouse Tracheas

Published on: June 12, 2019

7.2K

相关概念视频

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
49